PaySign Inc

PaySign, Inc. engages in the provision of prepaid card programs and processing services for corporate, consumer and government applications. It specializes in corporate incentive products, payroll cards, general purpose re-loadable cards, and travel cards. It markets its prepaid solutions through its PaySign brand. The company was founded by Mark R. Newcomer and Daniel H. Spencer on August 24, 1995 and is headquartered in Henderson, NV.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

PaySign Inc (PAYS) reports robust Q4 earnings and growth outlook

PaySign Inc (PAYS) delivered a strong financial performance in Q4 2022, with revenue growth, profitability, and operational achievements.
The company's focus on expanding its plasma business and patient affordability programs has been key drivers of growth and market differentiation.
Looking ahead, PaySign aims for continued growth in 2023, supported by revenue projections and strategic initiatives to drive profitability and market expansion.

PaySign Inc reports strong revenue growth, eyes plasma business expansion

PaySign Inc's Q1 2023 performance reflects solid revenue growth and operational progress, despite facing margin and profitability challenges.
The company's strengths lie in the growth potential of its Plasma and Patient affordability businesses, along with strategic industry partnerships.
While challenges persist in maintaining margins and addressing profitability, PaySign Inc has opportunities to drive growth through new center openings and market expansion.
Overall, PaySign Inc's financial position remains stable with a focus on executing its growth strategies and enhancing profitability.

PaySign Inc reports strong Q2 revenue growth and expansion plans

PaySign Inc (PAYS) delivered robust revenue growth in Q2 2023, driven by strong performance in key segments and a focus on expanding its market presence.
While facing challenges such as a net loss and increased SG&A expenses, the company remains optimistic about its growth prospects and profitability trajectory.
By capitalizing on opportunities in plasma compensation and patient affordability segments, PaySign Inc aims to sustain its growth momentum and enhance shareholder value.

PaySign Inc (PAYS) reports strong Q3 earnings and growth prospects

PaySign Inc (PAYS) delivered robust financial results in Q3 2023, showcasing growth across key business segments.
Despite challenges such as new center openings and contract delays, the company remains focused on meeting its financial targets.
With a strong balance sheet, diversified revenue streams, and strategic outlook, PaySign Inc (PAYS) is well-positioned for future success.

PaySign Inc reports stellar Q4 results, eyes growth opportunities

PaySign Inc delivered strong financial results in Q4 2023, with notable revenue growth and net income increase, driven by the success of its plasma and patient affordability segments.
The company's strategic focus on revenue diversification, technology development, and market expansion positions it well for future growth and competitive advantage.
While facing challenges in sustaining growth rates and navigating competitive landscapes, PaySign has opportunities to capitalize on market demand, innovation, and ethical business practices to drive continued success.
Overall, PaySign's performance highlights operational excellence, strategic foresight, and a commitment to delivering value to stakeholders, setting a positive trajectory for 2024 and beyond.

PaySign Inc reports robust Q1 earnings, eyes growth opportunities

PaySign Inc delivered impressive financial results in Q1 2024, driven by strong revenue growth and improved profitability.
While facing challenges in sustaining growth and market competition, the company remains optimistic about future prospects.
Strategic expansion in key business segments and a positive market reception position PaySign Inc for continued success.

PaySign Inc (PAYS) reports stellar Q2 results and raises 2024 guidance

PaySign Inc demonstrated robust financial performance in Q2 2024, driven by strong revenue growth, improved profitability, and expansion of key client relationships. While facing some challenges in specific business segments, the company's strategic initiatives and raised guidance indicate a positive trajectory for future growth and success.

PaySign Inc reports robust Q3 earnings, eyes strategic growth opportunities

PaySign Inc's Q3 2024 earnings call reflects a solid financial performance with revenue growth, improved margins, and strategic expansion initiatives.
While facing challenges in managing operating expenses and maintaining profit margins, the company is well-positioned to leverage opportunities for growth.
By focusing on diversification and efficiency, PaySign aims to achieve its revenue targets and strengthen its position in the market.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

The company has steadily amassed a dominant position in plasma centers and is set for further steady growth. Despite the loss of its prepaid pharma business, it's the pharma segment, still tiny, where additional growth seems now likely. The company has had some recent wins and is in talks with a number of big pharma companies.

PaySign Is Finally Getting Promising Traction In Its Pharma Business

HENDERSON, Nev.--(BUSINESS WIRE)--Paysign Successfully Completes Certification and Establishes Connection with Mastercard.

Paysign Successfully Completes Certification and Establishes Connection with Mastercard

HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. Expects to Join Russell 3000® Index.

Paysign, Inc. Expects to Join Russell 3000® Index

HENDERSON, Nev.--(BUSINESS WIRE)--Paysign and Spentra Announce Integration and Payroll Card Program – Program Enhances Value Throughout the Cardholder Experience.

Paysign and Spentra Announce Integration and Payroll Card Program

VAALCO Energy

Sirius XM Holdings Inc

Venturing into the realm of high potential penny stocks is a high-risk proposition. However, within the myriad of penny stocks, there exist a few emerging companies that offer an attractive business profile.

3 Penny Stocks to Buy Before They Soar to New Heights in 2023

HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. to Present at the Barrington Research Virtual Spring Investment Conference on May 18, 2023.

Paysign, Inc. to Present at the Barrington Research Virtual Spring Investment Conference

PaySign, Inc. (NASDAQ:PAYS ) Q1 2023 Earnings Conference Call May 10, 2023 5:00 PM ET Company Participants Mark Newcomer - Vice Chairman, President and Chief Executive Officer Jeff Baker - Chief Financial Officer Matt Turner - Vice President & Head of Patient Affordability Solutions Conference Call Participants Jon Hickman - Ladenburg Operator Good afternoon, everyone. My name is Kevin, and I'll be your conference operator today.

PaySign, Inc. (PAYS) Q1 2023 Earnings Call Transcript

First quarter total revenues of $10.1 million, up 23% from first quarter 2022 First quarter net loss of ($0.2) million, or diluted loss per share of ($0.00) First quarter Adjusted EBITDA of $0.7 million, down 22% from $0.9 million a year ago, while diluted Adjusted EBITDA per share was $0.01 versus $0.02 for the first quarter 2022 (Adjusted EBITDA and Adjusted EBITDA per share are non-GAAP metrics used by management to gauge the operating performance of the business - see reconciliation of net loss to Adjusted EBITDA at the end of the press release) Added 10 plasma donation centers during the first quarter, exiting the quarter with 439 centers Launched seven new patient affordability programs during the first quarter, exiting the quarter with 26 active programs First quarter gross dollar load volume up 17.1% versus the year-ago period First quarter gross spend volume was up 31.2% versus the year-ago period HENDERSON, NV / ACCESSWIRE / May 10, 2023 / Paysign, Inc. (NASDAQ:PAYS), a leading provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services and integrated payment processing, today announced financial results for the first quarter 2023. "We are pleased to report a solid Q1 2023 with revenue growth of 23% compared to last year, reflecting our continued expansion in the plasma and patient affordability verticals," said Mark Newcomer, CEO.

Paysign, Inc. Reports First Quarter 2023 Financial Results

HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. (NASDAQ: PAYS), a leading provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services and integrated payment processing, today announced it will present at the Ladenburg Thalmann Technology Expo in New York City on Thursday, April 27, 2023, at 2:30 p.m. EDT. Investors interested in attending may email techexpo@ladenburg.com for more information.

Paysign, Inc. to Present at the Ladenburg Thalmann Tech Expo 2023

HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. (NASDAQ: PAYS), a leading provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing, will discuss first quarter 2023 earnings at 5:00 p.m. Eastern time on Wednesday, May 10, 2023. Participant details are as follows: U.S. dial-in: 877.407.2988 International dial-in: +1.201.389.0923 Webcast: Click Here Replay: Dial-in: 877.660.6853 or 201.612.

Paysign to Host First Quarter 2023 Earnings Call

Paysign, Inc. (NASDAQ:PAYS ) Q4 2022 Earnings Conference Call March 21, 2023 5:00 PM ET Company Participants Mark Newcomer - Chief Executive Officer Jeff Baker - Chief Financial Officer Conference Call Participants Gary Prestopino - Barrington Research Peter Heckmann - D.A. Davidson Jon Hickman - Ladenburg Thalmann Operator Hello and welcome to the Paysign Fourth Quarter and Year End 2022 Earnings Conference Call and Webcast.

Paysign, Inc. (PAYS) Q4 2022 Earnings Call Transcript

HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc.

Paysign, Inc. Reports Fourth Quarter and Full-Year 2022 Financial Results

HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. (NASDAQ: PAYS), a leading provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services and integrated payment processing, today announced that its Board of Directors has authorized a new stock repurchase program of up to $5,000,000 of the company's outstanding common stock, par value $0.001 per share. This program will commence immediately and is expected to be completed over the next 36 months.

Paysign, Inc. Announces New $5,000,000 Stock Repurchase Program

Wilmington, Delaware--(Newsfile Corp. - February 10, 2023) - Rigrodsky Law, P.A. is investigating potential claims against the officers and directors of PaySign, Inc. (NASDAQ: PAYS) on behalf of stockholders.To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-paysign-inc.To contact Seth D. Rigrodsky or Gina M. Serra cost free, call or text (302) 295-5310 or email info@rl-legal.com.Rigrodsky Law, P.A.

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating PaySign, Inc.

PaySign is a microcap stock with a market cap of $177.12 million that has rewarded its investors with 68.0% returns over the last year. Before COVID-19, PaySign reported upward-trending top and bottom line results for five consecutive years.

PaySign: Plasma Donations Are Increasing Again

HENDERSON, Nev.--( BUSINESS WIRE )--Paysign, Inc. (NASDAQ: PAYS ), a leading provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing, and EvoShare, a microsavings-oriented fintech startup based in Berkeley, CA, today announced a new partnership and integrated experience to bring more savings and reward opportunities to Paysign clients and cardholders.

Paysign and EvoShare Announce Partnership

HENDERSON, Nev.--( BUSINESS WIRE )--Paysign, Inc. (NASDAQ: PAYS ), a leading provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services and integrated payment processing, today announced it will be presenting at the D.A. Davidson 2022 Fintech and Payments Spotlight Conference to be held Thursday, December 8, 2022, at Thompson Central Park Hotel in New York City.

Paysign, Inc. to Present at the D.A. Davidson Fintech and Payments Spotlight Conference

HENDERSON, Nev.--( BUSINESS WIRE )--Paysign, Inc. (NASDAQ: PAYS ), a leading provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services and integrated payment processing, today announced it will be presenting virtually at the Ladenburg Thalmann Virtual Technology Expo, Wednesday, December 7, 2022, at 3:30 p.m. EST.

Paysign, Inc. to Present at Ladenburg Thalmann Virtual Technology Expo

The positives and negatives of being heavily reliant on one market. Why PAYS should maintain a modest, positive growth trajectory in the quarters ahead.

PaySign: Steady As She Goes

HENDERSON, Nev.--( BUSINESS WIRE )--Paysign, Inc. (NASDAQ: PAYS ), a leading provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services and integrated payment processing, today announced it will be presenting at The Benchmark Company's 11th Annual Discovery One-on-One Investor Conference to be held Thursday, December 1, 2022, at the New York Athletic Club in New York City.

Paysign, Inc. to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference

PaySign, Inc. (NASDAQ:PAYS ) Q3 2022 Earnings Conference Call November 8, 2022 5:00 PM ET Corporate Participants Mark Newcomer - Co-Founder, Chairman and Chief Executive Officer Jeff Baker - Chief Financial Officer Conference Call Participants Gary Prestopino - Barrington Research Operator Hello and welcome to the PaySign Third Quarter 2022 Earnings Conference Call. As a reminder, this conference call is being recorded.

PaySign, Inc. (PAYS) Q3 2022 Earnings Call Transcript

Third quarter total revenues of $10.6 million, an increase of $2.8 million (36.4%) from third quarter 2021

Paysign, Inc. Reports Third Quarter 2022 Financial Results

HENDERSON, Nev.--(BUSINESS WIRE)--Paysign to Host Third Quarter 2022 Earnings Call

Paysign to Host Third Quarter 2022 Earnings Call

HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. Applauds Preliminary Injunction of Plasma Ban

Paysign, Inc. Applauds Preliminary Injunction of Plasma Ban

HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. to Participate in the H.C. Wainwright 24th Annual Global Investment Conference

News for PaySign Inc Stock (PAYS)